
AIM ImmunoTech Inc. an immuno-pharma company headquartered in Ocala Florida is focused on the research and development of therapeutics to treat multiple types of cancers as well as immune-deficiency disorders. We have established a strong foundation of laboratory pre-clinical and clinical data with ... AIM ImmunoTech Inc. an immuno-pharma company headquartered in Ocala Florida is focused on the research and development of therapeutics to treat multiple types of cancers as well as immune-deficiency disorders. We have established a strong foundation of laboratory pre-clinical and clinical data with respect to the development of nucleic acids and natural interferon to enhance the natural antiviral defense system of the human body and to aid the development of therapeutic products for the treatment of certain cancers and chronic diseases. AIM ImmunoTechs flagship products include Ampligen Rintatolimod a first-in-class drug of large macromolecular RNA ribonucleic acid molecules and Alferon N Injection Interferon Alfa-N3. Ampligen represents an RNA being developed for globally important cancers viral diseases and disorders of the immune system. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 9.1151 | 9604.95258166 | 0.0949 | 10.4 | 0.0949 | 6028 | 8.3 | CS |
4 | 9.1151 | 9604.95258166 | 0.0949 | 10.4 | 0.0949 | 1340 | 8.3 | CS |
12 | 9.0796 | 6962.88343558 | 0.1304 | 10.4 | 0.0633 | 69474 | 0.15561558 | CS |
26 | 9.0208 | 4767.86469345 | 0.1892 | 10.4 | 0.0633 | 548286 | 0.15985856 | CS |
52 | 8.82 | 2261.53846154 | 0.39 | 10.4 | 0.0633 | 446082 | 0.20331802 | CS |
156 | 8.4 | 1037.03703704 | 0.81 | 10.4 | 0.0633 | 260361 | 0.33851277 | CS |
260 | 6.86 | 291.914893617 | 2.35 | 10.4 | 0.0633 | 812064 | 2.02341176 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.